Skip to content
Sectors How it works Pricing Client stories

Insights

Companies Live signals Events Markets Trends Company lists
Log in
Platform Signal Tracker API Radar Book a 7-day Readout
ŌGI Bio logo — Offering our customers an affordable route into the automati...

ŌGI Bio

Offering our customers an affordable route into the automation of routine microbial culturing.

Founded 2020 United Kingdom Edinburgh, United Kingdom 11 employees Seed Total: $1.65M Biopharma, Biotechnology

General Information

Company Name ŌGI Bio
Founded Year 2020
Location United Kingdom Edinburgh, United Kingdom
Employees 11
Industries Biopharma, Biotechnology
Funding Stage Seed
Business Model B2B, SaaS, D2C
Revenue Model Product Sales, Service Fee, Subscription
Social

BounceWatch is an independent company data service, not affiliated with ŌGI Bio. To contact ŌGI Bio, visit ogibio.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does ŌGI Bio compare?

A PDF of ŌGI Bio and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting ŌGI Bio soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About ŌGI Bio

ŌGI Bio, founded in 2020, is a promising player in the biopharma and biotechnology industries, headquartered in the United Kingdom. The company is carving a niche by providing the microbiology sector an affordable pathway to automation through its innovative offerings.

Embodying its slogan, "Offering our customers an affordable route into the automation of routine microbial culturing," ŌGI Bio enables clients to enhance their research and development throughput. Their standout product is a modular, retrofittable device, which offers flexible and customizable automation solutions tailored to a customer’s specific needs, significantly aiding their progression in innovation.

In its latest financial milestone, ŌGI Bio garnered a £650.00K Seed Round investment on 18 June 2024 from notable investors including Scottish Enterprise, Apollo Global Management, Merleview Capital, Edinburgh Innovations, and TRICAPITAL Angels Limited, showcasing strong investor confidence in its growth potential.

Business keywords: microbial culturing, automation solutions, modular technology, retrofit devices, R&D acceleration, microbiology innovation, University spin-off, flexible laboratory tools, scientific research tools, laboratory automation, scientific equipment

Services & Products

Automated modular culturing systems
WiFi-enabled software for laboratory use
Comprehensive microbial growth analytics

Target Customers

Biotechnology Researchers Academic Institutions Lab Scientists Universities Biotech Startups Research Laboratories

Funding Rounds & Investors (2)

View All
Funding Stage Amount Investors Lead Investors Date
Seed Round £650.00K 5
Scottish Enterprise Apollo Global Management Merleview Capital
Scottish Enterprise, Apollo Global Management +3
18 Jun 2024
Seed Round £1.00M 5
Merleview Capital Apollo Informal Investments Sapphire Capital Partners LLP
Merleview Capital, Apollo Informal Investments +3
16 May 2022

ŌGI Bio Alternatives & Competitors

View All Alternatives
ŌGI Bio vs
BioNex Solutions
BioNex Solutions United States

At BioNex Solutions, we develop instrumentation and integrated systems that solve the most demanding...

Venture round
45 employees
Biopharma, Biotechnology
ŌGI Bio vs
Apostle Inc
Apostle Inc United States

Apostle is a provider of innovative technologies and services for public health and life sciences.

Series A
21 employees
Biopharma, Biotechnology
ŌGI Bio vs
Discover Echo Inc.
Discover Echo Inc. United States

Experience Precision in Biological Research with Advanced Automated Microscopy for Accurate Imaging...

Series A
68 employees
Biopharma, Biotechnology
View all alternatives

FAQ About ŌGI Bio

Offering our customers an affordable route into the automation of routine microbial culturing.
ŌGI Bio was founded in 2020.
ŌGI Bio is headquartered in Edinburgh, United Kingdom.
ŌGI Bio operates in Biopharma and Biotechnology. Its work centres on microbial culturing, automation solutions, modular technology and retrofit devices. Its customers include Biotechnology Researchers, Academic Institutions and Lab Scientists.
ŌGI Bio has a B2B, SaaS and D2C business model. Its revenue comes from Product Sales, Service Fee and Subscription.
ŌGI Bio has approximately 11 employees.
ŌGI Bio has completed 2 funding rounds, raising a total of $1.65M. The latest funding stage is Seed.
ŌGI Bio offers: Automated modular culturing systems, WiFi-enabled software for laboratory use, Comprehensive microbial growth analytics.
Top alternatives and competitors to ŌGI Bio include BioNex Solutions, Apostle Inc, Discover Echo Inc., Moonwalk Biosciences. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
ŌGI Bio and BioNex Solutions are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for ŌGI Bio, https://bouncewatch.com/company/aoegi-bio, updated 2 April 2026. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout